logo-loader
viewMotif Bio PLC

Motif Bio adds three to strengthen medical advisory board

"Each of them brings specific expertise that will be invaluable as we develop and prepare to commercialise iclaprim for patients with serious and life-threatening infections."

handshake picture
Icalprim is currently in a stage III trial

Antibiotic developer Motif Bio Plc (LON:MTFB) has appointed three new doctors to its scientific advisory board.

David Huang, chief medical officer of Motif Bio said: "We are delighted to welcome these three outstanding scientific leaders to our Clinical Advisory Board. Each of them brings specific expertise that will be invaluable as we develop and prepare to commercialise iclaprim for patients with serious and life-threatening infections."

Thomas Lodise is a Professor at Albany College of Pharmacy and Health Sciences, Albany, New York and an infectious diseases clinical pharmacy specialist at the Stratton VA Medical Center.

Thomas Holland is an Assistant Professor in the Department of Infectious Diseases at Duke University School of Medicine and Board certified in infectious disease.

William O'Riordan, is the founder and CEO of eStudy Sites, one of the pre-eminent network of clinical trial sites in the US He is certified with the American Board of Emergency Medicine and is the lead investigator at the Chula Vista Research Site in California. 

 

Quick facts: Motif Bio PLC

Price: 0.5 GBX

AIM:MTFB
Market: AIM
Market Cap: £3.27 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Britvic PLC sees acceleration in at-home channel sales lead by Pepsi-MAX in...

Britvic PLC (OTCQX:BTVCF) (LON:BVIC) Director of Investor Relations Stephen Nightingale tells Proactive the manufacturer of soft drinks saw an increase at-home channel sales with its slew of trusted soft drinks, despite a months-wide lockdown in the UK. Nightingale says its carbonates...

14 hours, 52 minutes ago

2 min read